BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
124 hedge funds and large institutions have $1.81B invested in Blueprint Medicines in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
30% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 33
35% less call options, than puts
Call options by funds: $2.75M | Put options by funds: $4.26M
Holders
124
Holding in Top 10
7
Calls
$2.75M
Puts
$4.26M
Top Buyers
| 1 | +$44.6M | |
| 2 | +$41.1M | |
| 3 | +$30.8M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$28.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| 1 | -$58.9M | |
| 2 | -$36.1M | |
| 3 | -$26.4M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$25.9M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$16.5M |